Giant Cell Arteritis

Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis
Richard Conway, Lorraine O’Neill, Geraldine M McCarthy, Conor C Murphy, Aurelie Fabre, Susan Kennedy, Douglas J Veale, Sarah M Wade, Ursula Fearon, Eamonn S Molloy

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-213488; DOI: 10.1136/annrheumdis-2018-213488
Comparison of magnetic resonance angiography and ¹⁸F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis
Kaitlin A Quinn, Mark A Ahlman, Ashkan A Malayeri, Jamie Marko, Ali Cahid Civelek, Joel S Rosenblum, Armin A Bagheri, Peter A Merkel, Elaine Novakovich, Peter C Grayson

Annals of the Rheumatic Diseases Aug 2018, 77 (8) 1165-1171; DOI: 10.1136/annrheumdis-2018-213102
Platelet activation, as measured by plasma soluble glycoprotein VI, is not associated with disease activity or ischaemic events in giant cell arteritis
Richard Conway, Anne Madigan, Niamh Redmond, Laura Helbert, Eamonn S Molloy, Eimear Dunne, Dermot Kenny, Geraldine McCarthy

Annals of the Rheumatic Diseases May 2018, annrheumdis-2018-213487; DOI: 10.1136/annrheumdis-2018-213487
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco, Sofia Ramiro, Christina Duftner, Florent L Besson, Thorsten A Bley, Daniel Blockmans, Elisabeth Brouwer, Marco A Cimmino, Eric Clark, Bhaskar Dasgupta, Andreas P Diamantopoulos, Haner Direskeneli, Annamaria Iagnocco, Thorsten Klink, Lorna Neill, Cristina Ponte, Carlo Salvarani, Riemer H J A Slart, Madeline Whitlock, Wolfgang A Schmidt

Annals of the Rheumatic Diseases May 2018, 77 (5) 636-643; DOI: 10.1136/annrheumdis-2017-212649
Response to: ‘The role of temporal artery biopsy in patients with giant cell arteritis is debated’ by Moiseev et al
Christian Dejaco, Sofia Ramiro, Christina Duftner, Wolfgang A Schmidt

Annals of the Rheumatic Diseases Mar 2018, annrheumdis-2018-213284; DOI: 10.1136/annrheumdis-2018-213284
The role of temporal artery biopsy in patients with giant-cell arteritis is debated
Sergey V Moiseev, Ilya Smitienko, Nikolay Bulanov, Pavel I Novikov

Annals of the Rheumatic Diseases Mar 2018, annrheumdis-2018-213282; DOI: 10.1136/annrheumdis-2018-213282
Response to: ’Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries' by Graver et al
Francesco Ciccia, Aroldo Rizzo, Carlo Salvarani, Giovanni Triolo

Annals of the Rheumatic Diseases Mar 2018, 77 (3) e17; DOI: 10.1136/annrheumdis-2017-211882
Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries
Jacoba Carolien Graver, Maria Sandovici, Arjan Diepstra, Annemieke M H Boots, Elisabeth Brouwer

Annals of the Rheumatic Diseases Mar 2018, 77 (3) e16; DOI: 10.1136/annrheumdis-2017-211860
Response to: ‘Is the PET/CT first choice for differential diagnosis of FUO/IUO?’ by Armagan et al
Verena Schönau, Georg Schett

Annals of the Rheumatic Diseases Feb 2018, annrheumdis-2017-212785; DOI: 10.1136/annrheumdis-2017-212785
Response to: ustekinumab inhibits Th1 and Th17 polarisation in a giant-cell arteritis patient by Samson et al
Richard Conway, Ursula Fearon, Eamonn S Molloy

Annals of the Rheumatic Diseases Feb 2018, 77 (2) e7; DOI: 10.1136/annrheumdis-2017-211669

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages